These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 29845702

  • 21. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
    Haynes RA, Phipps AJ, Yamamoto B, Green P, Lairmore MD.
    Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
    [Abstract] [Full Text] [Related]

  • 22. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y, Hasegawa A, Takamori A, Sasada A, Tanosaki R, Choi I, Utsunomiya A, Maeda Y, Yamano Y, Eto T, Koh KR, Nakamae H, Suehiro Y, Kato K, Takemoto S, Okamura J, Uike N, Kannagi M.
    J Immunol; 2013 Apr 15; 190(8):4382-92. PubMed ID: 23475215
    [Abstract] [Full Text] [Related]

  • 23. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
    Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H.
    J Virol; 1992 May 15; 66(5):2928-33. PubMed ID: 1373197
    [Abstract] [Full Text] [Related]

  • 24. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.
    Ohashi T, Hanabuchi S, Kato H, Tateno H, Takemura F, Tsukahara T, Koya Y, Hasegawa A, Masuda T, Kannagi M.
    J Virol; 2000 Oct 15; 74(20):9610-6. PubMed ID: 11000233
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE.
    Blood; 1998 Nov 15; 92(10):3557-61. PubMed ID: 9808547
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M, Hasegawa A, Nagano Y, Kimpara S, Suehiro Y.
    Retrovirology; 2019 Aug 22; 16(1):23. PubMed ID: 31438973
    [Abstract] [Full Text] [Related]

  • 34. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H, Ngato T, Sato K, Aoki N, Kimura S, Tanaka Y, Aizawa H, Tateno M, Celis E.
    Clin Cancer Res; 2006 Jun 15; 12(12):3814-22. PubMed ID: 16778109
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.
    Suzuki S, Masaki A, Ishida T, Ito A, Mori F, Sato F, Narita T, Ri M, Kusumoto S, Komatsu H, Fukumori Y, Nishikawa H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R.
    Cancer Sci; 2012 Oct 15; 103(10):1764-73. PubMed ID: 22735080
    [Abstract] [Full Text] [Related]

  • 39. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K, Shimizu Y, Takamori A, Harashima N, Noji M, Masuda T, Utsunomiya A, Okamura J, Kannagi M.
    J Immunol Methods; 2006 Jun 30; 313(1-2):61-73. PubMed ID: 16723135
    [Abstract] [Full Text] [Related]

  • 40. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N.
    Hum Immunol; 2011 Nov 30; 72(11):1001-6. PubMed ID: 21851845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.